Peptide record

TPDB46664

Antiviral standard
51 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB46664
Antiviral
Anti-infective peptides
Peptipedia
standard
No
A 51-aa standard-residue antiviral peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
QARQLLSGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKQQ
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C265H446N82O73
DCMFP
Q
5948.96
11.34
7
2
24
+4
1.58
-0.233
133.92
Mammalian: 0.8 hour Yeast: 10 min E.coli: >10 hour
6990
1.17
17
Residue Composition
number
5
A
4
R
2
N
0
D
0
C
2
E
12
Q
2
G
1
H
4
I
10
L
2
K
0
M
0
F
0
P
1
S
1
T
1
W
1
Y
3
V
Amino Acid Distribution
A: 5 R: 4 N: 2 D: 0 C: 0 E: 2 Q: 12 G: 2 H: 1 I: 4 L: 10 K: 2 M: 0 F: 0 P: 0 S: 1 T: 1 W: 1 Y: 1 V: 3
Chemical Descriptors
51 reviewed residue count
C265H446N82O73 sequence-only estimate (linear, free termini)
5948.96 sequence-only estimate (linear, free termini)
11.34 sequence-only estimate (linear, free termini)
+4 sequence-only estimate (linear, free termini)
1.58 sequence-only estimate (linear, free termini)
-0.233 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA